Methionine Metabolism Dictates PCSK9 Expression and Antitumor Potency of PD‐1 Blockade in MSS Colorectal Cancer
Advanced Science · 2025-05 · 12 (19)
DOI: 10.1002/advs.202501623 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 24.03.2025. Verfasst von Qi-Long Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 5…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Methionine, Proprotein Convertase 9, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Key-Area Research and Development Program of Guangdong Province.
Abstract (Originalsprache)
Nutrient metabolisms are vitally interrelated to cancer progression and immunotherapy. However, the mechanisms by which nutrient metabolisms interact to remodel immune surveillance within the tumor microenvironment remain largely unexplored. Here it is demonstrated that methionine restriction inhibits the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9), a key regulator of cholesterol homeostasis and a potential target for cancer immunotherapy, in colorectal cancer (CRC) but not in the liver. Mechanistically, methionine is catabolized to S‐adenosylmethionine (SAM), promoting mRNA transcription of PCSK9 through increased DNA methyltransferase 1 (DNMT1)‐mediated DNA methylation and suppression of sirtuin 6 (SIRT6) expression. Furthermore, both PCSK9 inhibition and dietary methionine restriction (DMR) potentiate PD‐1 blockade therapy and foster the infiltration of CD8 + T cells in Colon 26 tumor‐bearing mice—a proficient mismatch repair (pMMR)/microsatellite stable (MSS) CRC model that exhibits limited response to anti‐PD‐1 therapy. Moreover, combining 5‐fluorouracil (5‐FU) chemotherapy with PCSK9 inhibition and PD‐1 blockade further augments therapeutic efficacy for MSS CRC. The findings establish a mechanistic link between amino acid metabolism and cholesterol metabolism within the tumor microenvironment where tumor cells sense methionine to regulate PCSK9 expression, highlighting promising combination therapeutic strategies that may greatly benefit MSS CRC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
- Guangdong Provincial Key Laboratory of Molecular Oncologic Pathology, Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
- Department of Gastrointestinal Surgery, Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
- Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China.
ORCID-Profile: Wei Yang
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Key-Area Research and Development Program of Guangdong Province
- Guangdong Natural Science Funds for Distinguished Young Scholar
- Pearl River Talent Plan of Guangdong Province
- Natural Science Foundation of Guangdong Province
- Guangdong Basic and Applied Basic Research Foundation
- Guangzhou Science and Technology Plan Project
Zitieren
APA
Wang, Q. L., Chen, Z., Lu, X., Lin, H., Feng, H., Weng, N., Chen, L., Liu, M., Long, L., Huang, L., Deng, Y., Zheng, K., Zheng, X., Li, Y., Cai, T., Zheng, J., & Yang, W. (2025). Methionine Metabolism Dictates PCSK9 Expression and Antitumor Potency of PD‐1 Blockade in MSS Colorectal Cancer. Advanced Science, 12(19). https://doi.org/10.1002/advs.202501623
Vancouver
Wang QL, Chen Z, Lu X, Lin H, Feng H, Weng N, et al. Methionine Metabolism Dictates PCSK9 Expression and Antitumor Potency of PD‐1 Blockade in MSS Colorectal Cancer. Advanced Science. 2025;12(19). doi:10.1002/advs.202501623
BibTeX
@article{Wang2025,
author = {Wang, Qi-Long and Chen, Zijie and Lu, Xiaofei and Lin, Huizhen and Feng, Huolun and Weng, Nuozhou and Chen, Liwen and Liu, Mengnan and Long, Li and Huang, Lingjun and Deng, Yongmei and Zheng, Kehong and Zheng, Xiaojun and Li, Yong and Cai, Ting and Zheng, Jiabin and Yang, Wei},
title = {Methionine Metabolism Dictates PCSK9 Expression and Antitumor Potency of PD‐1 Blockade in MSS Colorectal Cancer},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {19},
doi = {10.1002/advs.202501623}
}
EUVIMED